Global Amblyopia Market was valued at USD 4327.0 Million in 2016, and is forecasted to grow at CAGR of 3.28% over the forecast period 2020–2026. The key factors driving the market growth include growing prevalence of ophthalmological disorders, increasing technological advancement and high healthcare expenditure.
Get Sample Report: https://dataintelo.com/request-sample/?reportId=73114
- Changing lifestyles and preferences
- High treatment costs
- Lack of results
- R&D by medical companies to develop new and effective treatments
On August 27, 2019, Smart Optometry Ltd, a Slovenia-based software solutions company, launched a subscription-based digital vision therapy platform, Amblyoplay, to help treat amblyopia. The platform allows parents or guardians to monitor progress and share the results with the doctor. This therapy requires around 30 minutes and can be conducted at home. AmblyoPlay provides a personalized vision therapy experience, which uses advanced algorithms that deliver precise stimuli to exercise and help improve vision.
Additionally, the platform provides monocular and binocular therapy. Monocular vision therapy caters to cases where one eye is worse than the other. In such cases the lazy eye needs to be developed before starting the binocular therapy, which strengthens the lazy eye, while training the brain to use both eyes together.